HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pranee Winichagoon Selected Research

beta-Thalassemia (Cooley's Anemia)

10/2010Expression of microRNA-451 in normal and thalassemic erythropoiesis.
3/2010A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E.
9/2009Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.
11/2008Association of SNP in exon 1 of HBS1L with hemoglobin F level in beta0-thalassemia/hemoglobin E.
5/2008Coinheritance of the different copy numbers of alpha-globin gene modifies severity of beta-thalassemia/Hb E disease.
9/2007Role of interleukin-3 and signaling pathways on beta-thalassemia/HbE erythroid progenitor cell in culture.
2/2007Characterization of a novel deletion causing (deltabeta)0-thalassemia in a Thai family.
3/2006Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
12/2005In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
1/2005Genetic analysis of candidate modifier polymorphisms in Hb E-beta 0-thalassemia patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pranee Winichagoon Research Topics

Disease

19Thalassemia
03/2022 - 08/2002
11beta-Thalassemia (Cooley's Anemia)
10/2010 - 10/2002
9alpha-Thalassemia
05/2010 - 05/2002
8Hydrops Fetalis (Fetal Edema)
01/2020 - 06/2005
2Anemia
08/2015 - 10/2002
2Inborn Genetic Diseases (Disease, Hereditary)
06/2009 - 08/2002
2Hemoglobinopathies
10/2008 - 02/2002
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
03/2022
1Hypoxia (Hypoxemia)
09/2016
1Iron Deficiencies
04/2015
1Hemolysis
09/2009

Drug/Important Bio-Agent (IBA)

14Hemoglobins (Hemoglobin)IBA
03/2022 - 08/2002
11GlobinsIBA
12/2020 - 06/2006
9hemoglobin Bart'sIBA
01/2020 - 06/2005
9alpha-GlobinsIBA
05/2010 - 06/2005
6DNA (Deoxyribonucleic Acid)IBA
12/2020 - 08/2002
6Hemoglobin EIBA
03/2010 - 08/2002
4beta-Globins (beta Globin)IBA
01/2020 - 08/2002
3hemoglobin A2'IBA
01/2020 - 06/2006
3Fetal Hemoglobin (Hemoglobin F)IBA
11/2008 - 12/2005
2MicroRNAs (MicroRNA)IBA
09/2016 - 10/2010
2Oligonucleotide ProbesIBA
05/2008 - 10/2002
2gamma-GlobinsIBA
05/2007 - 06/2006
2IgYIBA
06/2006 - 06/2006
2EnzymesIBA
06/2006 - 06/2006
2Sepharose (Agarose)IBA
06/2006 - 06/2006
2ImmunosorbentsIBA
06/2006 - 06/2006
2AntibodiesIBA
06/2006 - 06/2006
2Hydroxyurea (Hydrea)FDA LinkGeneric
03/2006 - 12/2005
1Messenger RNA (mRNA)IBA
01/2020
1Transferrin Receptors (Transferrin Receptor)IBA
09/2016
1IronIBA
04/2015
1Hemoglobin Constant SpringIBA
04/2015
1Proteins (Proteins, Gene)FDA Link
05/2010
1enhancer-binding protein AP-4IBA
11/2008
1Transcription Factors (Transcription Factor)IBA
11/2008
1hemoglobin DIBA
10/2008
1A-Form DNA (A-DNA)IBA
05/2008
1Interleukin-3 (Interleukin 3)IBA
09/2007
1CytokinesIBA
09/2007
11- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA
09/2007
1Coloring Agents (Dyes)IBA
06/2005
1hemoglobin HekinanIBA
05/2004
1gamma-glutamylaspartic acidIBA
05/2004
1Codon (Codons)IBA
10/2002
1gamma-AIBA
10/2002
1Abnormal HemoglobinsIBA
08/2002
1hemoglobin PyrgosIBA
05/2002
1hemoglobin SiamIBA
02/2002

Therapy/Procedure

1Therapeutics
04/2015
1Blood Transfusion (Blood Transfusions)
10/2002